
Cumulative viral load was associated with increased risk of kidney disease, suggesting that early viral suppression could decrease incidence of disease.

Cumulative viral load was associated with increased risk of kidney disease, suggesting that early viral suppression could decrease incidence of disease.

Health insurers will shell out $743 million in rebates to consumers under an Affordable Care Act (ACA) rule; the human papilloma virus (HPV) vaccine offers benefits to men who are not vaccinated; Apple is launching 3 studies to assess the Apple Watch’s ability to monitor health and medical conditions.

Finding a midlife risk factor for dementia—such as migraine—could allow for earlier detection of at‐risk patients.

All patients with metastatic breast cancer should undergo genetic testing based on the prevalence of P/LP variants in patients with metastatic breast cancer, which can have therapeutic implications.

According to a report from the US Census Bureau, the rising rate of the uninsured appears to be a result of a slump in Medicaid coverage. Health policy experts say the decline reflects efforts by the Trump administration to undermine the Affordable Care Act.

A new liquid biopsy test could detect microsatellite instability and tumor mutational burden, which can distinguish which patients are likely to respond to immune checkpoint inhibitors.

Juul is being investigated for making unauthorized safety claims, while the governor of New York proposes to ban flavored e-cigarettes; Sutter Health is being sued for its role in rising healthcare costs; a European doctor who uses telemedicine and internet prescribing to provide American women with mifepristone and misoprostol to induce abortion in the first trimester is suing the FDA.

In 2 studies published in The Lancet Neurology, ozanimod was well tolerated and had a lower relapse rate in patients with relapsing multiple sclerosis.

The meta-analysis showed that more than 1,125,000 men around the world have the inherited bleeding disorder; 418,000 of those have a severe version of the mostly undiagnosed disease. Previously, only 400,000 people globally were estimated to have hemophilia.

The agency has approved nintedanib (Ofev) to slow the rate of pulmonary function decline in adult patients with interstitial lung disease associated with systemic sclerosis or scleroderma.

School-based telemedicine was shown to potentially enhance healthcare benefits for children with chronic diseases, such as asthma, in rural and medically underserved communities, according to a study.

Human leukocyte antigen c (HLA‐C), a protein encoded by the HLA-C gene, plays an important role in protecting against both cancer and viruses. At the same time, it has been implicated in autoimmune diseases, including rheumatic diseases, though the mechanism by which it contributes to the pathogenesis of these diseases is not yet clear.

Oxycontin manufacturer rejects settlement for role in opioid epidemic and moves toward bankruptcy; new vaping-related respiratory illnesses reported; Senator Kamala Harris, D-California, a 2020 presidential candidate, proposes a new healthcare plan for veterans.

Employers are recognizing the need to modernize the employee health experience following research that demonstrates the disconnect between companies’ investment in health benefits and the impact on employee health.

The Harvard researchers designed this new device with consideration of the human pancreas, where islets—also known as islands of cells—receive glucose level information from the bloodstream, then adjust their insulin production.

A total of 45% of patients made at least 1 error when using an inhaler, and the number of errors per patient ranged from 1 to 6.

Cloud faxing can provide the opportunity for providers to be more productive and lower costs.

A study investigating the effects of weather and air pollution on migraine found that higher relative humidity was associated with higher odds of migraines during warmer seasons. Traffic-related pollutants was linked with migraines in colder weather.

Using vorinostat with pembrolizumab can help improve the efficacy of the immunotherapy in non–small cell lung cancer.

The proportion of people living with HIV with more than 90% adherence to antiretroviral therapy (ART) increased from 33.5% in 2001 to 52.4% in 2010.

Men without chronic obstructive pulmonary disease (COPD) showed an associated difference in bone quality based on their smoking status and pack-years, according to a new study.

A recent study explored the efficacy of brentuximab vedotin (BV) in patients with high-CD30–expressing non-Hodgkin lymphoma (NHL) to determine who is most likely to benefit.

Surprise medical billing and its impact on patients has garnered attention from media, healthcare stakeholders, and the federal government. Here are 5 things to know.

A recent study investigating orthostatic hypotension (OH)—a common condition among patients with Parkinson disease—found that the causality between OH and dementia may be bidirectional and early diagnosis is important to improve long-term prognosis.

Three studies published this year have examined the risks when patients with chronic pain abruptly stop taking opioids.

When assessing risk for coronary artery disease, excess stomach fat represents the greatest indicator, not overall body mass index, according to a new study.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

Health officials in New York are investigating vitamin E's connection to a string of vaping illnesses in the state; civil rights groups are suing the Trump administration over its decision to deport immigrants with life-threatening illnesses; an oncologist from MD Anderson Cancer Center met with President Trump about a potential nomination for FDA commissioner.

This week, the top managed care news included a diabetes drug showing positive results in treating heart failure; new lipid guidelines promoting the use of proprotein convertase subtilisin/kexin type 9 inhibitors; and a study finding doctors are more likely to prescribe opioids if they are in a hurry.

An Expanded Treatment Protocol study that provided expanded access of the FDA-approved ruxolitinib, which treats polycythemia vera (PV) in patients who are intolerant or resistant to hydoxyurea, affirmed the safety and efficacy findings of the trials used for approval.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
